OVERVIEW

Grave’s Disease presents an opportunity for organized multi-disciplinary care with treatment options including medication, radioactive iodine, and surgery. Established standards exist to guide treatment of hyperthyroidism, and novel therapeutics have been developed for thyroid eye disease. Panelists will participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management. Three case studies will be reviewed including: a common patient presentation, thyrotoxicosis, and pregnancy.

TARGET AUDIENCE

PCPs, medical oncology, geriatrician, geneticists, endocrinologists, H&N surgeons

LEARNING OBJECTIVES

1. Describe the diagnostic evaluation for a patient diagnosed with Grave’s hyperthyroidism.
2. Review principles of medical, surgical and radioactive iodine therapy.
3. Discuss evidence-based management strategies of Grave’s hyperthyroidism.

MODERATOR & PANELISTS:

Rachel Kelz, MD (Endocrine Surgery)
César A. Briceño, MD (Ophthalmology)
Jessica Berman, MD (Endocrinology)
Dan Pryma, MD (Nuclear Medicine)
Heather Wachtel, MD (Endocrine Surgery)

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.